Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2021 / Cilt: 31 - Sayı: 1

Is There any Other Disease Under the Newly DiagnosedDiabetes that is Difficult to Control?

Kontrol Edilmesi Zor Yeni Tanı Diyabette Altta Yatan Başka Bir Hastalık Olabilir Mi?

Pages
130–132
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We wantedto share a case with treatment-resistant hyperglycemia which is the cause of presentation of acromegaly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:High levels of growth hormone and insulin-like growth factor 1 contribute to tissue proliferation and hypertrophyin patients with acromegaly mostly due to growth hormone-secreting pituitary adenoma.
📊
Key Findings & Data:Growth hormone also induces lipolytic activities and insulin resistance, sopatients with acromegaly often present with impaired glucose tolerance and type 2 diabetes mellitus.
💡
Conclusion & Impact:We wantedto share a case with treatment-resistant hyperglycemia which is the cause of presentation of acromegaly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

High levels of growth hormone and insulin-like growth factor 1 contribute to tissue proliferation and hypertrophyin patients with acromegaly mostly due to growth hormone-secreting pituitary adenoma. Some phenotypic fea tures of acromegaly that make us to consider in the differential diagnosis are excessive growth of the hands andfeet and coarsening facial features. Growth hormone also induces lipolytic activities and insulin resistance, sopatients with acromegaly often present with impaired glucose tolerance and type 2 diabetes mellitus. We wantedto share a case with treatment-resistant hyperglycemia which is the cause of presentation of acromegaly.

Özet

Yüksek seviyedeki büyüme hormonu ve insülin benzeri büyüme faktörü 1, çoğunlukla büyüme hormonu salgılayanhipofiz adenomu nedeniyle akromegali hastalarında doku proliferasyonuna ve hipertrofiye katkıda bulunur. Ayırıcıtanıda düşünmemizi gerektiren akromegalinin bazı fenotipik özellikleri ellerin ve ayakların aşırı büyümesi ve yüzdekabalaşmadır. Büyüme hormonu ayrıca lipolitik etkilere ve insülin direncine neden olur, bu nedenle akromegalihastaları sıklıkla bozulmuş glukoz toleransı ve tip 2 diabetes mellitus ile ortaya çıkar. Akromegalinin ortaya çıkma sına neden olan tedaviye dirençli hiperglisemili bir vakayı paylaşmak istedik.

🔖

Cite This Article

AKAR, H., PATIR, D. Ç., KAYPAK, M. A., ÖZALP, F. R. (2022). Is There any Other Disease Under the Newly DiagnosedDiabetes that is Difficult to Control?. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 31 - Sayı: 1, 130–132. https://ajindex.com/articles/558057

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Silha JV, Krsek M, Hana V et. al Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol (Oxf). 2003;58(6):736- 42. [CrossRef] 2. Hannon AM, Thompson CJ, Sherlock M. Diabetes in Patients With Acromegaly. Curr Diab Rep. 2017;17(2):8. [CrossRef] 3. Claire Rochette, Thomas Graillon, Frederique Albarel, Isabelle Morange, Henry Dufour, Thierry Brue, Frederic Castinetti, Increased Risk of Persistent Glucose Disorders After Control of Acromegaly, Journal of the Endocrine Society. 2017;1(12):1531-9. [CrossRef] 4. Moller N, Jorgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009;30(2):152-77. [CrossRef] 5. Mercado M, Ramírez-Rentería C. Metabolic Complications of Acromegaly. Front Horm Res. 2018;49:20-8. [CrossRef] 6. Vilar L, Vilar CF, Lyra R, Naves LA. Acromegaly: clinical features at diagnosis. Pituitary. 2017;20(1):22-32. [CrossRef] 7. Guo X, Meng T4, Huang J et. al 3D Facial Analysis in Acromegaly: Gender-Specific Features and ClinicalCorrelations. Front Endocrinol (Lausanne). 2018;9:722. [CrossRef] 8. Reid TJ, Post KD, Bruce JN et. al Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol. 2010;72:203-8. [CrossRef]